登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Analyses for primary vs. non-primary outcome.
Analyses for primary vs. non-primary outcome.
收藏
Figshare
2015-12-02 更新
2026-04-29 收录
临床试验效果分析
结果分类评估
数据链接：
https://figshare.com/articles/dataset/_Analyses_for_primary_vs_non_primary_outcome_/278668
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
NA, not applicable.
应用场景：
创建时间：
2015-12-02
相关数据集
10(Framingham Equation) categories by treatment arm at baseline and 48 weeks.
心血管风险评估
临床试验效果分析
10(Framingham Equation) categories by treatment arm at baseline and 48 weeks.
NIAID Data Ecosystem
9
0
Number of the occurrence of the side effects between active and sham groups.
临床试验效果分析
Number of the occurrence of the side effects between active and sham groups.
NIAID Data Ecosystem
5
0
Distribution of the primary and secondary outcomes by study groups and the effect of the intervention on these outcomes.
临床试验效果分析
干预效果评估
Distribution of the primary and secondary outcomes by study groups and the effect of the intervention on these outcomes.
Figshare
2021-02-02 更新
4
0
Summary of treatment outcomes based on PP analysis stratified by age.
临床试验效果分析
年龄分层治疗效果
Summary of treatment outcomes based on PP analysis stratified by age.
NIAID Data Ecosystem
6
0
Changes in outcome parameters after treatment with empagliflozin and placebo.
糖尿病药物疗效
临床试验效果分析
Changes in outcome parameters after treatment with empagliflozin and placebo.
NIAID Data Ecosystem
4
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
